Filed before 2025Filed 4 January 2018
FLX Bio, Inc. raised $29.9M
FLX Bio, Inc., a biotech company based in South San Francisco, CA, raised $29.9M in a new equity round, according to a filing dated 4 January 2018.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 4 January 2018
- Round
- Equity round
- Amount sold
- $29.9M
- Offering size
- $59.9M
- Investors so far
- 10
- Based in
- South San Francisco, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 85% of the 1,729 tracked raises with an amount filed in 2018, and than 70% of the 160 in biotech.
RAPT Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 20 Jun 2019 | Amended filing | $37.1M | Another raise |
| 2 Jan 2019 | New filing | $22.6M | Another raise |
| 4 Jan 2018 | New filing | $29.9M | This raise |
| 5 May 2016 | New filing | $50M | Another raise |
More with Westlake BioPartners on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.